1979
DOI: 10.1097/00006534-197909000-00016
|View full text |Cite
|
Sign up to set email alerts
|

Capsular Contracture and Steroid-Related Complications After Augmentation Mammaplasty A Preliminary Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0
2

Year Published

1984
1984
2015
2015

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(6 citation statements)
references
References 0 publications
0
4
0
2
Order By: Relevance
“…2 Moreover, despite initial excellent results observed with steroidcontaining inflatable prostheses, at least over a short period, significant dose-related complications-including prosthesis ptosis, atrophy, thinning of overlying breast tissue, impending extrusion, and even CC-have been observed many years after implantation. 56,57 It is worth mentioning, however, that the rapid-acting, water-soluble methylprednisolone sodium succinate we have used immediately and 3 days later (instead of the previously described injection of longer-acting, practically insoluble triamcinolone acetonide 6-8 weeks after surgery) may have affected GC distribution and diffusion in the pocket. In fact, with the mostly used textured implants, strong adhesions form between the capsule and the implant membrane that make uniform distribution of the injected GC unlikely, invariably leading to GC pooling at the injection site and an increased complication rate.…”
Section: Table1 (Continued)mentioning
confidence: 97%
“…2 Moreover, despite initial excellent results observed with steroidcontaining inflatable prostheses, at least over a short period, significant dose-related complications-including prosthesis ptosis, atrophy, thinning of overlying breast tissue, impending extrusion, and even CC-have been observed many years after implantation. 56,57 It is worth mentioning, however, that the rapid-acting, water-soluble methylprednisolone sodium succinate we have used immediately and 3 days later (instead of the previously described injection of longer-acting, practically insoluble triamcinolone acetonide 6-8 weeks after surgery) may have affected GC distribution and diffusion in the pocket. In fact, with the mostly used textured implants, strong adhesions form between the capsule and the implant membrane that make uniform distribution of the injected GC unlikely, invariably leading to GC pooling at the injection site and an increased complication rate.…”
Section: Table1 (Continued)mentioning
confidence: 97%
“…There are numerous reports of GCs being implanted in local depots 13–18 . However, the steroid doses needed for therapeutic effects in the treatment or prevention of capsule contracture have resulted in adverse effects, impairing their current use.…”
mentioning
confidence: 99%
“…Son taux varie de 1 à 6 % selon les études [5,8]. Son existence peut être à l'origine d'une infection ou d'une coque péri-prothétique secondaire affirmée par des auteurs [6,9]. On constate cette complication le plus souvent dans les 24 heures postopéra-toires.…”
Section: Discussionunclassified